Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02467270
Brief Title: Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses (OPTIC)

First Submitted : June 2, 2015
First Submitted that Met QC Criteria : June 5, 2015
First Posted : June 10, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 1, 2019
Last Update Posted : July 3, 2019 (Estimate)